Under normal conditions, ZBTB16 acts as a transcriptional repressor that inhibits breast cancer proliferation and metastasis by upregulating ZBTB28 and antagonizing oncogenic factors such as BCL6/ZBTB27 [57]. Here, BCL6B is linked to breast cancer.